Tvardi Therapeutics, Inc. Common Stock (TVRD) News

Latest headlines that mention TVRD, newest first · each headline opens the original publisher

TVRD quote

Last price: $1.01
Day change: -5.61%
Next earnings: 2026-11-12

Quote & chart Expected move Insider trading IV rank history

TVRD headlines

latest coverage

Not much coverage yet. TVRD has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Investing.com 1mo ago

Lucid Capital Markets initiates Tvardi stock with buy rating

General T3LCID TVRD

Seeking Alpha News 1mo ago

Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis - Slideshow

General T2TVRD

Seeking Alpha News 1mo ago

Tvardi Therapeutics, Inc. (TVRD) Discusses TTI-109 Development Program and Data in Ulcerative Colitis Transcript

General T2TVRD

Seeking Alpha 2mo ago

Tvardi Therapeutics GAAP EPS of -$0.69 misses by $0.06

Earnings T2TVRD

Seeking Alpha News 3mo ago

Tvardi Therapeutics, Inc. (TVRD) Discusses Phase 1 Data on TTI-109 STAT3 Inhibitor Highlighting Prodrug Design, Tolerability and Target Engagement Transcript

General T2TVRD

Seeking Alpha 4mo ago

Ocugen, Assertio among healthcare stocks set to join Russell Microcap; Definium Therapeutics, Tvardi Therapeutics to exit

General T2ASRT DFTX OCGN TVRD

Seeking Alpha 5mo ago

Tvardi Therapeutics GAAP EPS of -$0.73 misses by $0.04

Earnings T2TVRD

TVRD news alerts

Get an alert by email or push when a new headline mentions TVRD.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.